Nashan, B <br/><br/>
Immunoprophylaxis with a monoclonal anti-IL-2 receptor antibody in liver transplant patients.  [electronic resource] 

 -  Transplantation  Feb 1996 
 - 546-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/00007890-199602270-00006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Animals<br/>Antibodies, Monoclonal--adverse effects<br/>Antilymphocyte Serum--therapeutic use<br/>Azathioprine--therapeutic use<br/>Bacterial Infections--etiology<br/>Candidiasis--etiology<br/>Cyclosporine--therapeutic use<br/>Female<br/>Graft Rejection--prevention & control<br/>Humans<br/>Immunoglobulin M--biosynthesis<br/>Immunosuppressive Agents--adverse effects<br/>Liver Transplantation--adverse effects<br/>Male<br/>Mice<br/>Middle Aged<br/>Prospective Studies<br/>Rabbits<br/>Receptors, Interleukin-2--immunology